Essity retains private label business and sells stake in tissue producer Vinda

In April 2023, Essity announced that it would initiate a review of this division in order to reduce the share of Consumer Tissue in the company’s total sales revenues. The review was completed in December 2023 and concluded that the division was a competitive and value-creating part of the group as a result of the divisionalisation process.